EMA has published an overview of its key recommendations of 2024 regarding the authorisation and safety monitoring of veterinary medicines. In 2024, EMA recommended...
OverviewThis is a summary of the European public assessment report (EPAR) for Opatanol. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
OverviewRekambys is used together with another medicine called cabotegravir to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that...
OverviewVocabria is used together with another medicine called rilpivirine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that...
